Oncology Institute (TOIIW) EBT Margin (2021 - 2026)

Oncology Institute has reported EBT Margin for 6 years, with the latest figure at 1.69% in Q1 2026.

• For the quarter ending Q1 2026, EBT Margin rose 1707.0% year-over-year to 1.69%; the trailing twelve-month figure through Mar 2026 stood at 8.0% (up 797.0% YoY), and the FY2025 full-year result was 12.08%, up 435.0% from the prior year.
• EBT Margin for Q1 2026 stood at 1.69%, up from 5.29% in the prior quarter.
• The five-year high for EBT Margin was 35.29% in Q1 2022, with the low at 39.31% in Q1 2023.
• Historically, EBT Margin has averaged 12.67% across 5 years, with a median of 15.7% in 2024.
• Annual changes were most pronounced in 2022 — EBT Margin surged 3689 bps — and 2023, when it tumbled 7460 bps.
• Oncology Institute's EBT Margin stood at 15.92% in 2022, then slumped by 40 bps to 22.23% in 2023, then surged by 41 bps to 13.15% in 2024, then surged by 60 bps to 5.29% in 2025, then soared by 68 bps to 1.69% in 2026.
• The last three EBT Margin figures came in at 1.69% (Q1 2026), 5.29% (Q4 2025), and 12.09% (Q3 2025), per Business Quant data.